[1] Sieqel RL,Miller KD,Jemal A. Cancer statistics,2016[J]. CA Cancer J Clin,2016,66(1):7-30.[2] 刘中阳,闫泽晨,郑 豪,等.膀胱癌相关基因的研究现状与展望[J]. 医学与哲学,2015,36(4):67-69.[3] Zhang N,Li D,Shao J,et al. Animal models for bladder cancer:The model establishment and evaluation (Review)[J]. Oncol Lett,2015,9(4):1515-1519.[4] 李 涛,杨 立,王志平. 鼠膀胱癌原位模型建立的研究进展[J]. 现代泌尿生殖肿瘤杂志,2013,5(1):51-53.[5] Xiao Z,McCallum TJ,Brown KM,et al. Characterization of a novel transplantable orthotopic rat bladder transitional cell tumour model[J]. Br J Cancer,1999,81(4):638-646.[6] Hicks RM,Wakefield JS. Rapid induction of bladder cancer in rats with N-methyl-N-nitrosourea.Ⅰ.Histology[J]. Chem Biol Interact,1972,5(2):139-152.[7] 张 祥,许天源,夏磊磊,等. 原位膀胱癌大鼠建模方法比较及超声鉴定方法[J]. 现代泌尿生殖肿瘤杂志,2015,7(2):99-103.[8] Li J,Qu W,Cheng Y,et al. The inhibitory effect of intravesical fisetin against bladder cancer by induction of p53 and down-regulation of NF-kappa B pathways in a rat bladder carcinogenesis model[J]. Basic Clin Pharmacol Toxicol,2014,115(4):321-329.[9] 吴志平,石家齐,由慧娟,等. N-甲基亚硝基脲诱导大鼠膀胱肿瘤动物模型的实验研究[J]. 贵州医学,2012,36(3):205-208.[10] 杨劲松. 实验动物的福利伦理与"3R"原则[J]. 河南医学研究,2015,24(8):64-65.[11] 颜汝平,王剑松,徐鸿毅. 膀胱癌的动物实验模型[J]. 国外医学:泌尿系统分册,2005,25(4):446-449.[12] 丁 鸿,钱立新. 大鼠膀胱癌模型建立的实验研究[J]. 实验动物与比较医学,2007,27(1):32-36.[13] Asanuma H,Arai T,Seguchi K,et al. Successful diagnosis of orthotopic rat superficial bladder tumor model by ultrathin cystoscopy[J]. J Urol,2003,169(2):718-720.[14] 潘春武,胡明明,唐小莹,等. 大鼠原位膀胱癌模型的建立及CT鉴定方法[J]. 现代泌尿生殖肿瘤杂志,2011,3(1):29-33.[15] 郝钢跃,张维东,田 野,等. 浅表性膀胱癌模型的建立及其活体荧光成像[J]. 中华肿瘤防治杂志,2009,16(24):1932-1934.[16] Kikuchi E,Xu S,Ohori M,et al. Detection and quantitative analysis of early stage orthotopic murine bladder tumor using in vivo magnetic resonance imaging[J]. J Urol,2003,170(4Pt1):1375-1378. |